Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumtani, Thailand.
Blood Transfus. 2011 Jul;9(3):306-10. doi: 10.2450/2010.0051-10. Epub 2010 Sep 13.
The direct antiglobulin test is performed to determine whether an anaemic patient with evidence of haemolysis has autoimmune or alloimmune haemolytic anaemia.
We determined the antibody specificity of eluted IgG antibodies from patients' blood samples with a positive direct antiglobulin test. Overall, 134 Thai patients were included in this study. EDTA blood samples were obtained from recently transfused patients, patients with unexplained anaemia and patients who had serum antibodies detected during routine pre-transfusion tests from different hospital blood banks. These complicated samples were sent to the National Blood Centre of the Thai Red Cross Society for investigation and to find compatible blood components. Each blood sample underwent a direct antiglobulin test with the gel technique using polyspecific antihuman globulin and mononospecific anti-IgG and anti-C3d. Acid eluates were prepared from the samples for which the direct antiglobulin test was positive and the specificities of the eluted antibodies were determined by the gel technique.
Of the samples tested, 101 showed a positive direct antiglobulin test result (75.4%) using polyspecific antihuman globulin sera whereas only 95 samples (70.9%) were positive with anti-IgG or anti-IgG and anti-C3d. Moreover, 54 of 95 eluates (56.8%) were positive for antibody screening and tested with the reagent panel cells. Twenty-one eluates had specific alloantibodies, which were concordant with the findings in the patients' sera and all patients had a history of blood transfusion. Additionally, 33 eluates contained pan-agglutinins. Interestingly, alloantibodies could be determined using titration studies in 5 of 26 eluates with pan-agglutinins.
Although the direct antiglobulin test is not routinely performed in pre-transfusion screening, this test and elution studies would be useful in patients with a history of previous transfusions, and in those for whom compatible blood cannot be found.
直接抗球蛋白试验用于确定是否患有溶血性贫血且有溶血性贫血证据的贫血患者患有自身免疫性或同种免疫性溶血性贫血。
我们从直接抗球蛋白试验阳性的患者血液样本中洗脱 IgG 抗体,并确定其抗体特异性。总共纳入了 134 名泰国患者。EDTA 血液样本取自近期输血的患者、原因不明贫血患者以及在不同医院血库的常规输血前检测中发现血清抗体的患者。这些复杂的样本被送往泰国红十字会国家血液中心进行调查,并寻找相容的血液成分。每份血液样本均进行直接抗球蛋白试验,使用多特异性抗人球蛋白和单特异性抗 IgG 和抗 C3d 进行凝胶技术检测。对直接抗球蛋白试验阳性的样本进行酸洗脱,并通过凝胶技术确定洗脱抗体的特异性。
在用多特异性抗人球蛋白血清检测的样本中,有 101 例(75.4%)呈直接抗球蛋白试验阳性,而仅 95 例(70.9%)用抗 IgG 或抗 IgG 和抗 C3d 呈阳性。此外,54 例(56.8%)洗脱液在抗体筛选中呈阳性,并与试剂盘细胞进行了检测。21 例洗脱液含有特异性同种异体抗体,与患者血清中的发现一致,所有患者均有输血史。此外,33 例洗脱液含有全凝集素。有趣的是,在 26 例含有全凝集素的洗脱液中,有 5 例可以通过滴定研究确定同种异体抗体。
尽管直接抗球蛋白试验未常规用于输血前筛查,但该试验和洗脱研究对有既往输血史且无法找到相容血液的患者可能有用。